Citation

Rochet T, Revol O, Maillet J, de Villard R. Ann. Pediatr. (Paris) 1993; 40(9): 555-563.

Vernacular Title

Les psychotropes en psychiatrie de l'enfant et de l'adolescent.

Affiliation

Service de Psychopathologie de l'Enfant et de l'Adolescent, Hôpital Neurologique et Neurochirurgical Pierre-Wertheimer, Lyon.

Copyright

(Copyright © 1993, Societe Edition Assoc, Enseignement Med. Hop De Paris)

DOI

unavailable

PMID

8279803

Abstract

Although there has been concern about the use of psychoactive drugs in children, evidence is accumulating that these drugs are beneficial. The various groups of currently available drugs are reviewed with their pharmacological characteristics, adverse effects, dosages, and uses in children. Benzodiazepines, both widely used and severely criticized, are effective when used correctly, in particular for the shortest possible length of time. Antidepressants are indicated in many conditions including depression, obsessive-compulsive disorders, and anxiety; some of their indications are specific to children, such as separation anxiety, enuresis, and school phobia. Neuroleptics have a less well defined role and are usually given as symptomatic treatment, although their use is limited by their side effects. This is also true of lithium, despite fairly good tolerability in children. Carbamazepine was introduced in psychiatry too recently to allow valid evaluation. Psychostimulants are viewed with fear in France despite their documented efficacy in hyperkinetic children. A few other drugs used in other fields of medicine are currently being investigated in psychiatry (beta-blockers, clonidine, naloxone). A debate on drugs used in child psychiatry is much needed in particular to overcome the methodological and ethical problems raised by controlled trials of which few have been conducted to date. Drug therapy should be combined with psychotherapy to place the target symptoms in perspective with regard to the child's overall make-up.

Language: fr